166 filings
Page 5 of 9
6-K
VALN
Valneva SE
23 Jun 22
Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15
1:30pm
6-K
VALN
Valneva SE
15 Jun 22
Valneva Announces Settlement Agreement with the UK Government
5:14pm
6-K
VALN
Valneva SE
10 Jun 22
Valneva Provides Update on European Inactivated, Whole-Virus COVID-19 Vaccine Program VLA2001
5:00pm
6-K
VALN
Valneva SE
8 Jun 22
Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate, Host Symposium at NECTM8
5:00pm
6-K
VALN
Valneva SE
3 Jun 22
Valneva Appoints Dr. Thomas Decker and Dr. Michael Pfleiderer to its Scientific Advisory Board
5:00pm
6-K
VALN
Valneva SE
25 May 22
Valneva Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikungunya Vaccine Candidate
5:00pm
6-K
VALN
Valneva SE
20 May 22
Current report (foreign)
10:19am
6-K
VALN
Valneva SE
16 May 22
Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine
1:00pm
6-K
VALN
Valneva SE
5 May 22
Current report (foreign)
4:59pm
6-K
VALN
Valneva SE
26 Apr 22
Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate
11:00am
6-K
VALN
Valneva SE
19 Apr 22
Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine
6:00am
6-K
VALN
Valneva SE
25 Mar 22
Valneva Reports Full Year 2021 Results and Provides Corporate Updates
7:24am
20-F
2021 FY
VALN
Valneva SE
24 Mar 22
Annual report (foreign)
12:32pm
6-K
VALN
Valneva SE
22 Mar 22
Valneva Announces Renewal of the Term of Office of its Management Board Members
1:00pm
6-K
VALN
Valneva SE
14 Mar 22
Valneva Provides Regulatory Update on its COVID-19 Vaccine Candidate
9:00am
6-K
VALN
Valneva SE
8 Mar 22
Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate
5:00pm
6-K
VALN
Valneva SE
1 Mar 22
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
9:00am
6-K
VALN
Valneva SE
23 Feb 22
Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development
4:30pm
SC 13G
VALN
Valneva SE
10 Feb 22
Valneva SE / Bpifrance Participations ownership change
10:54am
6-K
VALN
Valneva SE
4 Feb 22
Valneva Reports Full Year 2021 Revenue and Cash; Provides First 2022 Guidance
9:00am